NASDAQ
OMDA
Last Price
US $22.62
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Omada Health carries no debt; cash flow comfortably covers obligations.
Financial stability - Healthy cash flow growth.
Omada Health's free cash flow has increased -144.50% from $-38.04M last year to $16.93M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Omada Health's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Omada Health's debt has decreased relative to shareholder equity from 0.47 last year to 0.00 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Omada Health has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Omada Health earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Omada Health's profit margin has increased (-91.99%) in the last year from -27.76% to -2.22%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Omada Health's short-term assets of $272.93M exceed its short-term liabilities of $75.73M
Decreasing performance - ROA.
Omada Health's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Omada Health's return on equity of -2.81%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Omada Health's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Omada Health had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Increasing performance - Free cash flow.
Omada Health has positive free cash flow, indicating the company generates cash after capital expenditures
Decreasing performance - FCF yield.
Omada Health has a free cash flow yield of 1.36%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Increasing performance - Healthy earnings growth.
Omada Health's yearly earnings has increased -72.89% since last year from $-47.14M to $-12.78M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Omada Health's yearly revenue has increased 53.24% since last year from $169.80M to $260.21M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -3.57% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Omada Health's 3-year revenue CAGR of 42.89% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Omada Health had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Omada Health had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Omada Health has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Omada Health has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Omada Health is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Omada Health has an EV/EBITDA ratio of 2.10Kx, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Overvalued - PEG ratio value.
Omada Health has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Omada Health has a price-to-book ratio of 5.26x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Undervalued - P/S ratio.
Omada Health has a price-to-sales ratio of 4.38x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-2.81%
Return on equity
ROIC: -3.57%
Valuation History
-182.1X
Price to Earnings
EV/EBITDA: 2098.0X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Fair Value
Market $22.62
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.